USE OF CHEMICALLY MODIFIED HEPARIN DERIVATES IN SICKLE CELL DISEASE

• 收藏
• 分享

专利权人:

MODUS THERAPEUTICS AB

发明人:

MATS WAHLGREN,HANS-PETER EKRE,ANNA LEITGEB,DAGMAR PIKAS

申请号：

PT12859384

公开号：

PT2794666T

申请日:

2012.12.19

申请国别(地区):

PT

年份:

2018

代理人:

摘要：

The present invention relates to a chemically modified heparin, with an antifactor II activity of less than 10 IU/mg, an antifactor Xa activity of less than 10 IU/mg and an average molecular weight (Mw) between about 6.5 and 9.5 kDa. Also disclosed is a method of preparing the heparin and its medical use, including treatment of malaria.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/